TNKS2 and acute myeloid leukemia: The results showed that PARP1, PARP2, PARP3, PARP4, PARP5b, PARP6, PARP8, PARP9, PARP10, PARP11, PARP12, PARP13, PARP14, PARP15, and PARP16 were differentially expressed in AML patients compared to normal bone marrow cells (P < 0.05, Figure 1 and Supplementary Figure 1).